Lakhan Kashyap

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 98 citations · Full text

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 74 citations

Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)

Lakhan Kashyap, Vijay Patil, Vanita Noronha et al. · ecancermedicalscience · 2021 · 19 citations · Full text

Surgical Oncology, Medicine, Metronomic Therapy +12

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort

Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol et al. · The Breast · 2022 · 12 citations · Full text

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer

Vanita Noronha, Vijay Patil, Pankaj Chaturvedi et al. · European Journal of Cancer · 2024 · 11 citations